When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L
- PMID: 8486339
When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L
Similar articles
-
Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.Semin Oncol. 1993 Oct;20(5 Suppl 7):21-3. Semin Oncol. 1993. PMID: 8235691 Clinical Trial.
-
CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.Nouv Rev Fr Hematol (1978). 1988;30(5-6):449-52. Nouv Rev Fr Hematol (1978). 1988. PMID: 2906118 Clinical Trial.
-
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.Cancer. 1997 Jun 1;79(11):2107-14. Cancer. 1997. PMID: 9179056 Clinical Trial.
-
Current results and prospective trials of cladribine in chronic lymphocytic leukemia.Semin Hematol. 1996 Jan;33(1 Suppl 1):23-7. Semin Hematol. 1996. PMID: 8714613 Review. No abstract available.
-
Clinical challenges in chronic lymphocytic leukemia.Semin Hematol. 1998 Jul;35(3 Suppl 3):22-6. Semin Hematol. 1998. PMID: 9685176 Review. No abstract available.
Cited by
-
Palliative therapies in elderly cancer patients.Drugs Aging. 1995 Mar;6(3):192-209. doi: 10.2165/00002512-199506030-00003. Drugs Aging. 1995. PMID: 7542508 Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources